| Michele Jacobson, CADC-I | |
|
1490 Grimes St, Fallon, NV 89406-3103 | |
| (775) 423-1412 | |
| (775) 423-4054 |
| Full Name | Michele Jacobson |
|---|---|
| Gender | Female |
| Speciality | Counselor - Addiction (substance Use Disorder) |
| Location | 1490 Grimes St, Fallon, Nevada |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477943488 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YA0400X | Counselor - Addiction (substance Use Disorder) | 01559 (Nevada) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Michele Jacobson, CADC-I 1490 Grimes St, Fallon, NV 89406-3103 Ph: (775) 423-1412 | Michele Jacobson, CADC-I 1490 Grimes St, Fallon, NV 89406-3103 Ph: (775) 423-1412 |
News Archive
Perrigo Company today announced that its partner, PharmaForce/Luitpold Pharmaceuticals, received final approval for Epinastine HCl ophthalmic solution, 0.05%, a generic version of Elestat. Perrigo will commence shipment of the product immediately.
The results of a study conducted by Dr. Anick Bérard, Professor and Fonds de recherche du Québec - Santé Research Chair on Medications and Pregnancy, at the University of Montreal's Faculty of Pharmacy and the Ste-Justine University Hospital demonstrate that the use of nicotine patches or the drug Zyban has positive effects for the unborn child and allows pregnant women to stop smoking during and after pregnancy.
This post in the Center for Global Health Policy's "Science Speaks" blog reports on a presentation at the Union World Conference on Lung Health in France on Saturday by Evelyne Kibuchi, a senior tuberculosis (TB) advocacy officer at the Kenya AIDS NGOs Consortium (KANCO), writing, "HIV stakeholders have been slow to embrace and adopt TB interventions, Kibuchi said, and resources for co-infection activities are modest.
Pfizer announced today that the European Commission has approved Vyndaqel (tafamidis) for the treatment of Transthyretin Familial Amyloid Polyneuropathy (TTR-FAP) in adult patients with stage 1 symptomatic polyneuropathy.
University of British Columbia researcher Hongshen Ma has developed a simple and accurate device to study malaria, a disease that currently affects 500 million people per year worldwide and claims a million lives.
› Verified 3 days ago
Keturah Tackett, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1490 Grimes St, Fallon, NV 89406 Phone: 775-423-1412 Fax: 775-423-4054 | |
Kathy Melendy, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1490 Grimes St, Fallon, NV 89406 Phone: 775-423-1412 Fax: 775-423-4054 | |
Charles Crane, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1490 Grimes St, Fallon, NV 89406 Phone: 775-753-6962 Fax: 775-753-4736 | |
Joseph Knapp, Counselor Medicare: Not Enrolled in Medicare Practice Location: 295 E Williams Ave, Fallon, NV 89406 Phone: 775-217-5936 | |
Janera Tucker, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1490 Grimes St, Fallon, NV 89406 Phone: 775-423-1412 Fax: 775-423-4054 | |
Kadie Zeller, Counselor Medicare: Not Enrolled in Medicare Practice Location: 5855 Sheckler Rd, Fallon, NV 89406 Phone: 949-394-8406 | |
Macie Shay Anderson, CADC-I Counselor Medicare: Not Enrolled in Medicare Practice Location: 1490 Grimes St, Fallon, NV 89406 Phone: 775-423-1490 |